Description
Elsevier Food and Drug Administration’s Role in Dermatology An Issue of Dermatologic Clinics 1st Edition by Luke, Markham C.
In this issue, guest editors bring their considerable expertise to this important topic.Provides in-depth reviews on the latest updates in the field, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews. The History of Dermatology and Dermatologists at the US Food and Drug AdministrationThe Food and Drug Administration's Role in Dermatologic Drug DevelopmentPostmarket Assessment for Drugs and Biologics Used in Dermatology and Cutaneous Adverse Drug ReactionsHow Does the Food and Drug Administration Approve Topical Generic Drugs Applied to the Skin?Dermatology Drugs for Children-U.S. Food and Drug Administration PerspectiveRegulation of Medical Devices for DermatologyRegulation of Cosmetics in the United StatesCutaneous Pharmacokinetic Approaches to Compare Bioavailability and/or Bioequivalence for Topical Drug ProductsMeasuring What Matters to Patients in Dermatology Drug Development: A Regulatory Perspective